|
|
|
MIRA
INFORM REPORT
|
Report No. : |
493412 |
|
Report Date : |
28.02.2018 |
·
Given name is a short name
·
Given Address is Head Offices Address of the
Company
IDENTIFICATION DETAILS
|
Name : |
LABIALFARMA-LABORATORIO DE PRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA |
|
|
|
|
Registered Office : |
Rua do centro empresarial (EE6) 303, 2º, Quinta da
Beloura, 2710-693-sintra, lisboa |
|
|
|
|
Country : |
Portugal |
|
|
|
|
Financials (as on) : |
2016 |
|
|
|
|
Date of Incorporation : |
28.04.1992 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Subject engaged In Manufacture of Medicines |
|
|
|
|
No. of Employees : |
279 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
Euro 249.399,00 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
Portugal |
B1 |
B1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
PORTUGAL - ECONOMIC OVERVIEW
Portugal has become a diversified and increasingly service-based economy since joining the European Community - the EU's predecessor - in 1986. Over the following two decades, successive governments privatized many state-controlled firms and liberalized key areas of the economy, including the financial and telecommunications sectors. The country joined the Economic and Monetary Union in 1999 and began circulating the euro on 1 January 2002 along with 11 other EU members.
The economy grew by more than the EU average for much of the 1990s, but the rate of growth slowed in 2001-08. After the global financial crisis in 2008, Portugal’s economy contracted in 2009 and fell into recession from 2011 to 2013, as the government implemented spending cuts and tax increases to comply with conditions of an EU-IMF financial rescue package, signed in May 2011. Portugal successfully exited its EU-IMF program in May 2014, and its economic recovery gained traction in 2015 because of strong exports and a rebound in private consumption. GDP growth accelerated in 2016, and probably reached 2.5 % in 2017. Unemployment remained high, at 9.7% in 2017, but has improved steadily since peaking at 18% in 2013.
The center-left minority Socialist government has unwound some unpopular austerity measures while managing to remain within most EU fiscal targets. The budget deficit fell from 11.2% of GDP in 2010 to 1.8% in 2017, the country’s lowest since democracy was restored in 1974, and surpassing the EU and IMF projections of 3%. Portugal exited the EU’s excessive deficit procedure in mid-2017.
|
Source
: CIA |
Company name
LABIALFARMA-LABORATORIO DEPRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA
FINANCIAL HIGHLIGHTS
|
|
2014 |
2015 |
2016 |
|
net sales |
14.017.386,45 |
14.364.764,19 |
15.394.158,78 |
|
net income for |
|
604.404,84 |
1.002.606,68 |
|
the year |
551.742,87 |
|
|
|
shareholders |
|
|
|
|
|
5.494.105,63 |
6.041.143,39 |
6.945.683,50 |
|
funds |
|
|
|
|
stocks |
2.829.280,62 |
2.810.472,10 |
3.631.066,84 |
|
liability |
8.676.557,49 |
8.167.108,02 |
9.631.472,65 |
|
assets |
14.170.663,12 |
14.208.251,41 |
16.577.156,15 |
SUMMARY
|
Legal Form |
Joint Stock Company |
|
|
|
Constitution |
28-04-1992 |
|
|
|
V.A.T. Number / NIF |
502755954 |
|
|
|
Employees |
279 |
|
|
|
Capital |
4.500.000,00 |
|
|
|
Sales in : 31-12-2016 |
15.394.158,78 |
|
|
|
Shareholders Funds in: 31-12-2016 |
6.945.683,50 |
|
|
|
Credit Limit |
249.399,00 |
|
|
|
Actual Condition |
In activity |
|
|
|
Import/Export |
Sim / Sim |
|
|
TAX
SITUATION
On this date the subject is Not registered in the debtors
list of the tax authorities
CONTRIBUTIVE
SITUATION (SOCIAL SECURITY)
At present date, the company is not in Social Security debt
list
INSOLVENCIES
/ REVITALIZATION PROCESSES
NO
SUMMARY
OF CLAIMS (LAST 5 YEARS)
|
YEAR |
QUANTITY |
TOTAL |
|
|
|
€ |
|
2016 |
1 |
363.000,00 |
|
Total |
1 |
363.000,00 |
IDENTIFICATION
|
Name |
LABIALFARMA-LABORATORIO DE
PRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA |
|
Trust Nº. |
73411 |
|
V.A.T. Number / NIF |
502755954 |
|
Address |
Rua do Centro Empresarial (EE6) 303, 2º, Quinta da Beloura |
|
Postal Code |
2710-693-SINTRA |
|
Municipality |
SINTRA |
|
District |
LISBOA |
|
Country |
Portugal |
|
Telephone |
231927590 |
|
Fax |
231929165 |
|
E-Mail |
email@labialfarma.com |
|
Web Site |
www.labialfarma.pt |
|
CAE Main |
21201- Manufacture of medicines |
GOVERNING BODIES
Board
of Director's
|
AMILCAR JOSE DOS REIS FERRAZ |
|
Board of Director's President |
|
MARIA DE LURDES RIBEIRO DA SILVA FERRAZ |
|
Board of Director's Member |
|
DANIELA FILIPA RIBEIRO FERRAZ |
|
Board of Director's Member |
Fiscal Board
|
MARQUES DE ALMEIDA,
J. NUNES, V. SIMOES & ASSOCIADOS,
SROC SA |
Unique Fiscal |
|
BRUNO JOSE MACHADO DE ALMEIDA |
Fiscal Board Substitute |
LEGAL STRUCTURE
Registed on the Register Record
Office of Sintra with the Register Number 502755954 previous number 38 in 06
-05-1992
Constitution celebrated in 28-04-1992
published on Diário da República number 143 of 24-06-1992
To oblige the company it is
necessary 1 signatures
CHANGES
TO SOCIETY
In 20-11-2017 on Portal MJ of 20-11-2017 increase of capital
In 06-11-2017 on Portal MJ of 06-11-2017 social change
In 09-03-2017 on Portal MJ of 09-03-2017 head office change
In 10-08-2016 on Portal MJ of 10-08-2016 social change
In 20-07-2016 on Portal MJ of 20-07-2016 renewal of the
governing bodies
In 18-07-2016 on Portal MJ of 18-07-2016 annual financial
statements
In 20-07-2015 on Portal MJ of 20-07-2015 annual financial
statements
In 20-10-2014 on Portal MJ of 20-10-2014 board of
director's change
In 18-07-2014 on Portal MJ of 18-07-2014 annual financial
statements
In 18-07-2013 on Portal
MJ of 18-07-2013 annual financial
statements
CAPITAL
The Capital is 4.500.000,00 , divided in 3000000 shares ,
with a nominal value of 1,00
BIOGRAPHIES
|
Name |
AMILCAR JOSE DOS REIS FERRAZ |
|
Funtion |
Board of Director's President |
|
Historical of Professional |
|
|
|
he subject had links with the following company(ies): |
|
Connections and Participations
T |
|
|
|
AZENTIS-PRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA como
Administrador Único. |
|
Links to others companies |
The subject has connections with the following company
(ies) |
|
|
CONSTRUCOES SOCITAR, L.DA as Managing -Partner with a
participation of 30.250,00 , in a capital of 55.000,00 . |
|
|
LIQFILLCAPS INTERNATIONAL-INNOVATIVE PHARMACEUTICAL
PRODUCTS LDA as Managing-Partner with
a participation of 5.000,00 , in a capital of 500.000,00 |
|
|
GESCONSULTING-SERVICOS ESPECIALIZADOS DE GESTAO LDA as
Partner with a participation of 2.500,00 , in a capital of 5.000,00 . |
|
|
NUTRI.ADD-HEALTHCARE ADVANCED SOLUTIONS SA as Board of
Director's President . |
|
|
WELLCARE-PACKAGING LDA as Managing-Partner with a
participation of 25.000,00 , in a capital of 100.000,00 |
|
Name |
MARIA DE LURDES RIBEIRO DA SILVA FERRAZ |
|
Funtion |
Board of Director's Member |
|
Links to others companies |
The subject has connections with the following company
(ies) |
|
|
LIQFILLCAPS INTERNATIONAL-INNOVATIVE PHARMACEUTICAL
PRODUCTS LDA as Partner with a participation of 5.000,00 , in a capital of
500.000,00 . |
|
|
NUTRI.ADD-HEALTHCARE ADVANCED SOLUTIONS SA as Board of
Director's Member |
|
|
. WELLCARE-PACKAGING LDA as Managing-Partner with a participation
of 25.000,00 , in a capital of 100.000,00 . |
|
Name |
DANIELA FILIPA RIBEIRO FERRAZ |
|
Funtion |
Board of Director's Member |
|
Links to others companies |
The subject has connections with the following company
(ies) |
|
|
WESCIENCE-SCIENCE-BASED NUTRACEUTICALS UNIPESSOAL LDA as
Managing-Partner with a participation of 5.000,00, in a capital of 5.000,00 |
ACTIVITIES
|
Main CAE |
|
21201- Manufacture of medicines |
|
|
|
|
|
BUSINESS DESCRIPTION
Laboratório de biologia
alimentar e farmacêutica
GEOGRAPHIC DISTRIBUTION OF SALES
|
|
INTERNAL MARKET |
INTERNATIONAL MARKET |
|||||
|
YEAR |
|
|
EU |
|
EXTRA-EU |
|
TOTAL |
|
2016 |
13.927.244,51 |
90,47% |
1.463.360,65 |
9,51% |
3.553,62 |
0,02% |
15.394.158,78 |
|
2015 |
13.229.903,82 |
92,10% |
1.104.048,83 |
7,69% |
30.811,54 |
0,21% |
14.364.764,19 |
|
2014 |
13.085.202,23 |
93,35% |
923.530,67 |
6,59% |
8.653,55 |
0,06% |
14.017.386,45 |
|
2013 |
13.390.369,62 |
95,56% |
603.378,94 |
4,31% |
18.486,68 |
0,13% |
14.012.235,24 |
|
2012 |
10.367.705,81 |
94,16% |
399.320,48 |
3,63% |
244.101,99 |
2,22% |
11.011.128,28 |
GEOGRAPHIC DISTRIBUTION OF PURCHASES
|
INTERNAL MARKET |
INTERNATIONAL MARKET |
||||||
|
YEAR |
|
|
EU |
|
EXTRA-EU |
|
TOTAL |
|
2016 |
5.019.733,54 |
55,56% |
3.188.933,39 |
35,30% |
825.434,04 |
9,14% |
9.034.100,97 |
|
2015 |
4.011.747,29 |
52,78% |
2.754.316,88 |
36,24% |
834.252,98 |
10,98% |
7.600.317,15 |
|
2014 |
4.233.525,20 |
55,55% |
2.680.612,65 |
35,18% |
706.521,05 |
9,27% |
7.620.658,90 |
|
2013 |
4.941.382,78 |
60,29% |
2.270.011,94 |
27,70% |
985.065,10 |
12,02% |
8.196.459,82 |
|
2012 |
3.172.290,73 |
55,30% |
2.060.674,94 |
35,93% |
503.053,67 |
8,77% |
5.736.019,34 |
BANKS AND FINANCIAL INSTITUTIONS
|
MILLENNIUM BCP |
Mortagua |
|
CAIXA GERAL DE
DEPOSITOS, SA |
Mortágua |
|
BANCO SANTANDER TOT A SA |
Mortágua |
INCIDENTS
INSOLVENCIES
/ REVITALIZATION PROCESSES
NO
TAX
SITUATION
On this date the subject is Not registered in the debtors
list of the tax authorities
CONTRIBUTIVE
SITUATION (SOCIAL SECURITY)
At present date, the company is not in Social Security debt
list
SUMMARY
OF CLAIMS (LAST 5 YEARS)
|
YEAR |
QUANTITY |
TOTAL |
|
|
|
€ |
|
2016 |
1 |
363.000,00 |
|
Total |
1 |
363.000,00 |
|
LEGAL
ACTIONS |
|
|
Date |
17-09-2016 |
|
Process |
17101/16.6T8SNT |
|
Author |
Trade Medic, Sa |
|
Type |
Common Process Action |
|
Amount |
363.000,00 |
|
Judicial District |
Sintra - Trib. Jud. Com. de Lisboa Oeste |
|
Date |
24-09-2013 |
|
Process |
672/13.6TBSCD |
|
Author |
Maria Carmen Garriga Brosa |
|
Type |
Common Process Action |
|
Amount |
58.610,00 |
|
Judicial District |
Lisboa - Tribunal da Propriedade Intelectual |
|
Date |
15-03-2013 |
|
Process |
213/13.5TBSCD |
|
Author |
Goldfarma- Comercio de Produtos Farmaceuticos Ldª |
|
Type |
Action of Ordinary Process |
|
Amount |
77.438,00 |
|
Judicial District |
Viseu - Trib. Jud. Com. de Viseu |
EMPLOYEES
|
YEAR |
TOTAL |
MEN |
|
WOMEN |
|
|
2016 |
279 |
101 |
36% |
178 |
64% |
|
2015 |
269 |
102 |
38% |
167 |
62% |
|
2014 |
249 |
97 |
39% |
152 |
61% |
|
2013 |
212 |
80 |
38% |
132 |
62% |
|
2012 |
176 |
63 |
36% |
113 |
64% |
INSURANCE
Companhia de Seguros Fidelidade Mundial
HEAD
OFFICE AND INSTALLATIONS
Has head office Rua do Centro Empresarial (EE6) 303, 2º,
Quinta da Beloura, 2710 -693, SINTRA Had head office Lugar Felgueira, 1, Edif.
Labialfarma, 3450 -336, SOBRAL MRT
PARTICIPATIONS
|
NAME |
LIQFILLCAPS INTERNATIONAL-INNOVATIVE PHARMACEUTICAL
PRODUCTS LDA |
|
Trust Nº. |
908978 |
|
Address |
FELGUEIRA-SOBRAL |
|
Locality |
3450-336 SOBRAL MRT |
|
Country |
PORTUGAL |
|
Telephone |
231927590 |
|
Fax |
231929165 |
|
E-Mail |
liqfillcaps@liqfillcaps.com |
|
Web Site |
http://www.liqfillcaps.com |
|
C.A.E. |
46460- Wholesale trade of pharmaceutical products |
|
Capital |
500.000,00 |
|
Participation |
98% |
FINANCIAL DEMONSTRATION SNC
|
COINEUROS |
|
|
|
YEAR:2016 |
|
|
2016 |
2015 |
2014 |
%VAR.2016/15 |
|
ASSET |
|
|
|
|
|
NON-CURRENT ASSETS |
|
|
|
|
|
Tangible fixed assets |
4.205.357,22 |
3.835.979,90 |
4.139.044,93 |
9,63% |
|
Investment properties |
- |
- |
- |
- |
|
Goodwill |
- |
- |
- |
- |
|
Intangible assets |
102.762,00 |
54.361,00 |
58.325,00 |
89,04% |
|
Biological assets |
- |
- |
- |
- |
|
Financial participations - patrimonial equity method |
278.585,46 |
258.229,69 |
107.593,67 |
7,88% |
|
Financial participations - other methods |
49.810,00 |
49.810,00 |
49.810,00 |
- |
|
Shareholders/partners |
- |
- |
- |
- |
|
Other financial assets |
12.236,71 |
7.165,38 |
3.294,73 |
70,78% |
|
Deferred tax assets |
428.175,24 |
501.817,41 |
455.924,38 |
(14,68)% |
|
Financial investments(exclusive use by small entities and
micro entities) |
- |
- |
- |
- |
|
Total |
5.076.926,63 |
4.707.363,38 |
4.813.992,71 |
7,85% |
|
CURRENT
ASSETS |
|
|
|
|
|
Inventories |
3.631.066,84 |
2.810.472,10 |
2.829.280,62 |
29,20% |
|
Biological assets |
- |
- |
- |
- |
|
Costumers |
6.755.066,41 |
5.485.807,52 |
5.437.072,89 |
23,14% |
|
Advances to suppliers |
47.769,71 |
60.834,12 |
111.102,18 |
(21,48)% |
|
State and other public entities |
122.766,00 |
109.501,74 |
154.031,64 |
12,11% |
|
Shareholders/partners |
- |
- |
- |
- |
|
Other accounts receivable |
146.111,25 |
322.217,92 |
314.418,49 |
(54,65)% |
|
Deferrals |
49.820,30 |
80.834,91 |
57.828,49 |
(38,37)% |
|
Financial assets held for trading |
- |
- |
- |
- |
|
Other financial assets |
- |
- |
- |
- |
|
Non-current assets held for sale |
- |
- |
- |
- |
|
Other current assets |
- |
- |
- |
- |
|
Cashier and bank deposits |
747.629,01 |
631.219,72 |
452.936,10 |
18,44% |
|
Total |
11.500.229,52 |
9.500.888,03 |
9.356.670,41 |
21,04% |
|
TOTAL ASSET |
16.577.156,15 |
14.208.251,41 |
14.170.663,12 |
16,67% |
SHAREHOLDERS
FUNDS AND LIABILITIES
SHAREHOLDERS
FUNDS
|
Capital |
3.000.000,00 |
3.000.000,00 |
3.000.000,00 |
- |
|
Own shares |
- |
- |
- |
- |
|
Other shareholders funds instruments |
- |
- |
- |
- |
|
Emission premiuns |
- |
- |
- |
- |
|
Legal reserves |
367.522,82 |
337.302,58 |
309.715,44 |
8,96% |
|
Other reserves |
402.311,33 |
402.311,33 |
402.311,33 |
- |
|
Net retained |
1.795.056,42 |
1.357.653,09 |
841.013,30 |
32,22% |
|
Adjustments on financial assets |
(334.979,69) |
(335.466,84) |
(285.615,70) |
(0,15)% |
|
Revaluation surplus |
674.938,39 |
674.938,39 |
674.938,39 |
- |
|
Other shareholders funds changes |
38.227,55 |
- |
- |
- |
|
Total |
5.943.076,82 |
5.436.738,55 |
4.942.362,76 |
9,31% |
|
Net income for the period |
1.002.606,68 |
604.404,84 |
551.742,87 |
65,88% |
|
Antecipated dividends |
- |
- |
- |
- |
|
TOTAL OF SHAREHOLDERS FUNDS |
6.945.683,50 |
6.041.143,39 |
5.494.105,63 |
14,97% |
|
LIABILITY |
|
|
|
|
|
NON-CURRENT LIIABILITIES |
|
|
|
|
|
Provisions |
- |
- |
- |
- |
|
Financing obtained |
1.995.298,19 |
2.849.907,44 |
3.193.480,74 |
(29,99)% |
|
Responsability for post-employment beneficts |
- |
- |
- |
- |
|
Diferred taxes liabilities |
- |
- |
- |
- |
|
Other payable accounts |
- |
- |
- |
- |
|
Total |
1.995.298,19 |
2.849.907,44 |
3.193.480,74 |
(29,99)% |
|
CURRENT LIABILITIES |
|
|
|
|
|
Suppliers |
1.980.815,84 |
990.837,16 |
1.382.350,81 |
99,91% |
|
Advances from costumers |
117.815,80 |
54.074,71 |
167.967,30 |
117,88% |
|
State and other public entities |
539.253,52 |
425.493,95 |
603.235,65 |
26,74% |
|
Shareholders/partners |
607,50 |
- |
- |
- |
|
Financing obtained |
4.022.676,12 |
2.960.650,34 |
2.426.328,37 |
35,87% |
|
Other payable accounts |
975.005,68 |
886.144,42 |
903.194,62 |
10,03% |
|
Deferrals |
- |
- |
- |
- |
|
Financial liabilities held for trading |
- |
- |
- |
- |
|
Other financial liabilities |
- |
- |
- |
- |
|
Non-current liabilities held for sale |
- |
- |
- |
- |
|
Other current liabilities |
- |
- |
- |
- |
|
Total |
7.636.174,46 |
5.317.200,58 |
5.483.076,75 |
43,61% |
|
TOTAL LIABILITIES |
9.631.472,65 |
8.167.108,02 |
8.676.557,49 |
17,93% |
|
TOTAL SHAREHOLDERS FUNDS AND LIABILITIES |
16.577.156,15 |
14.208.251,41 |
14.170.663,12 |
16,67% |
|
INCOME
STATEMENT |
|
|
|
|
|
INCOME AND EXPENSES |
|
|
|
|
|
Sales and services |
15.394.158,78 |
14.364.764,19 |
14.017.386,45 |
7,17% |
|
Operating government grants |
62.895,41 |
51.038,78 |
45.222,23 |
23,23% |
|
Gains/losses allocated subsidiaries, associates and joint
ventures |
19.868,62 |
487,16 |
96.663,16 |
3.978,46% |
|
Variation in production inventories |
102.831,53 |
(3.192,08) |
(161.586,73) |
(3.321,46)% |
|
Work for the entity itself |
- |
- |
- |
- |
|
Cost of goods sold and materials consumed |
5.627.128,01 |
5.193.925,88 |
5.119.709,25 |
8,34% |
|
Suppliers and external services |
2.689.209,75 |
2.399.853,19 |
2.487.996,98 |
12,06% |
|
Personnel costs |
5.283.524,77 |
5.265.131,32 |
4.922.717,18 |
0,35% |
|
Impairment of inventories (losses/revearsals) |
- |
- |
- |
- |
|
Impairment of receivables (losses/revearsals) |
(13.623,59) |
- |
42.456,39 |
- |
|
Provisions (increases/reductions) |
- |
- |
- |
- |
|
Impairment of investments not depreciable/amortizable
(losses/reversals) |
- |
- |
- |
- |
|
Other impairments (losses/reversals)/impairments
(losses/reversals) (exclusive |
|
|
|
|
|
|
- |
- |
- |
- |
|
use by small entities and microentities) |
|
|
|
|
|
Increases/decreases in fair value |
54,78 |
22,31 |
- |
145,54% |
|
Other income and gains |
234.544,03 |
191.984,24 |
438.532,00 |
22,17% |
|
Other expenses and losses |
100.961,24 |
190.244,46 |
244.605,83 |
(46,93)% |
|
Result before depreciation, financing costs and taxes |
2.127.152,97 |
1.555.949,75 |
1.618.731,48 |
36,71% |
|
Expenses/reversals of depreciation and amortization |
746.856,02 |
704.937,94 |
767.060,62 |
5,95% |
|
Impairment of investments depreciable/amortizable
(losses/reversals) |
- |
- |
- |
- |
|
Operating result (before financing costs and taxes) |
1.380.296,95 |
851.011,81 |
851.670,86 |
62,19% |
|
Interest and similar income obtained |
- |
- |
- |
- |
|
interest and similar expenses incurred |
262.734,51 |
263.685,84 |
307.076,00 |
(0,36)% |
|
Net before taxes |
1.117.562,44 |
587.325,97 |
544.594,86 |
90,28% |
|
Income tax of the period |
114.955,76 |
(17.078,87) |
(7.148,01) |
(773,09)% |
|
Net profit for the period |
1.002.606,68 |
604.404,84 |
551.742,87 |
65,88% |
|
Results of discontinued operations (net of taxes) included
in the net icome of the period |
- |
- |
- |
- |
RATIOS SNC
|
YEAR |
2016 |
2015 |
2014 |
|
TURNOVER RATIOS |
|
|
|
|
Shareholder's Funds Profitability (Net Income / Shareholders Funds) (%) |
14,43 |
10,00 |
10,04 |
|
Return on Assets (Operating Result / Total Asset)(%) |
8,33 |
5,99 |
6,01 |
|
Sales Net
Profitability (Net Income /
Sales) (%) |
6,51 |
4,21 |
3,94 |
|
EFFICIENCY RATIOS |
|
|
|
|
Medium Term Receivable (Costumers / Sales) * 365 (d) |
160,16 |
139,39 |
141,58 |
|
Medium Term Payable (Suppliers / Purchases + Suppliers and
external services)*365 (d) |
80,03 |
47,58 |
66,21 |
|
Asset Rotation (Sales / Toral Asset) (%) |
92,86 |
101,10 |
98,92 |
|
PRODUCTIVITY RATIOS |
|
|
|
|
Gross Added Value / Employee (#) |
26.441,33 |
25.355,28 |
26.053,18 |
|
Sales / Employee (#) |
55.176,20 |
53.400,61 |
56.294,72 |
|
Productivity (Gross
Added Value / Personnel costs) (#) |
1,40 |
1,30 |
1,32 |
|
SHORT TERM RATIOS |
|
|
|
|
General Liquidity
(Current Assets / Current Liabilities)
(#) |
1,51 |
1,79 |
1,71 |
|
Reduced Liquidity (Current
Assets - Inventories / Current
Liabilities) (#) |
1,03 |
1,26 |
1,19 |
|
Immediate Liquidity (Cashier and bank deposits
/ Current Liabilities) (#) |
0,10 |
0,12 |
0,08 |
|
MEDIUM LONG TERM RATIOS |
|
|
|
|
Financial Autonomy (Shareholders Funds / Total Asset) (%) |
41,90 |
42,52 |
38,77 |
|
Solvability(Shareholders
Funds / Total Liabilities) (%) |
72,11 |
73,97 |
63,32 |
|
Debt Structure
(Current Liabilities / Total
Liabilities) (%) |
79,28 |
65,11 |
63,19 |
|
General Debt (Total
Liabilities / Total Asset) (%) |
58,10 |
57,48 |
61,23 |
|
Debt Capacity
(Shareholders Funds / Shareholders Funds
+ Non Current Liabilities)(%) |
77,68 |
67,95 |
63,24 |
|
Capital Structure (Shareholder's Funds
/ Non Current Liabilities) (%) |
348,10 |
211,98 |
172,04 |
|
OPERATIONAL AND FINANCIAL RISK |
|
|
|
|
Operational
Leverage Level (OLL) (Gross
Margin / Operating Result) (#) |
7,08 |
10,78 |
10,45 |
|
Financial Leverage Level
(FLL) (Gross Operating Profit / Operating Result) (#) |
1,24 |
1,45 |
1,56 |
|
Combined Leverage Level
(OLL x FLL) (#) |
8,74 |
15,61 |
16,34 |
CASH FLOW STATEMENT
|
RUBRICS |
2016 |
2015 |
PERIODS |
|
Customers receipts |
18.102.303,87 |
17.311.791,90 |
4,57% |
|
Payments to suppliers |
9.140.178,27 |
10.208.892,52 |
(10,47)% |
|
Payments to employees |
3.146.120,38 |
3.149.752,23 |
(0,12)% |
|
Cash at bank generated from operations |
5.816.005,22 |
3.953.147,15 |
47,12% |
|
Payment/receipt
ofincome tax |
(42.078,42) |
(3.055,17) |
(1.277,29)% |
|
Other receipts/payments |
(4.309.501,22) |
(2.924.734,38) |
(47,35)% |
|
Cash Flows from Operational Activities (A) |
1.464.425,58 |
1.025.357,60 |
42,82% |
|
CASH FLOWS' INVESTMENT ACTIVITIES |
|
|
|
|
Payments regarding: |
|
|
|
|
Fixed tangible assets |
493.979,39 |
443.507,18 |
11,38% |
|
Intangible assets |
49.200,00 |
226,32 |
21.639,13% |
|
Financial investments |
7.361,62 |
6.548,96 |
12,41% |
|
Other assets |
20.602,97 |
- |
- |
|
Receipts from: |
|
|
|
|
Fixed tangible assets |
- |
- |
- |
|
Intangible assets |
- |
- |
- |
|
Financial investments |
2.294,34 |
2.220,11 |
3,34% |
|
Other assets |
- |
- |
- |
|
Investment subsidies |
- |
- |
- |
|
Interest and
similar income |
- |
- |
- |
|
Dividends |
- |
- |
- |
|
Cash Flows' Investments Activities (B) |
(561.878,43) |
(448.062,35) |
(25,40)% |
|
CASH FLOWS' INVESTMENT ACTIVITIES |
|
|
|
|
Receipts from: |
|
|
|
|
Obtained financing |
560.000,00 |
1.574.565,20 |
(64,43)% |
|
Paying-up of capital and other equity instruments |
- |
- |
- |
|
Coverage of losses |
- |
- |
- |
|
Donations |
- |
- |
- |
|
Other financing operations |
- |
- |
- |
|
Payments regarding: |
|
|
|
|
Obtained financing |
1.162.274,54 |
1.744.174,00 |
(33,36)% |
|
Interests and
similar expenses |
175.845,26 |
218.295,10 |
(19,45)% |
|
Dividends |
- |
- |
- |
|
Capital's redution
and other equity instruments |
- |
- |
- |
|
Other financing operations |
- |
- |
- |
|
Cash Flows' Financing Activities © |
(778.119,80) |
(387.903,90) |
(100,60)% |
|
Variation in cash at bank
and its equivalents (A+B+C) |
124.427,35 |
189.391,35 |
(34,30)% |
|
Effect of exchange
differences |
(8.018,06) |
(11.107,73) |
27,82% |
|
Cash at bank and its equivalents at the start of period |
631.219,72 |
452.936,10 |
39,36% |
|
Cash at bank and its equivalents at the end of period |
747.629,01 |
631.219,72 |
18,44% |
CASH FLOWS
|
|
MOVIMENTOS DO PERIODO DE 2016 |
|
|
|
|
|
RUBRICS |
INITIAL BALANCE |
DEBITS |
|
CREDITS |
FINAL BALANCE |
|
PERIOD'S CARRYING AMOUNT AND MOVEMENTS |
|
|
|
|
|
|
Cash in hand |
11.214,02 |
7.885.106,40 |
7.867.870,66 |
|
28.449,76 |
|
Order deposits |
620.005,70 |
30.524.973,58 |
30.425.800,03 |
|
719.179,25 |
|
Other bank deposits |
- |
- |
|
- |
0,00 |
|
Total cash at bank and bank deposits |
631.219,72 |
38.410.079,98 |
38.293.670,69 |
|
747.629,01 |
|
Of which: Bank deposits abroad |
- |
- |
|
- |
0,00 |
|
RUBRICS |
|
|
|
|
VALUE |
|
OTHER
INFORMATION |
|
|
|
|
|
|
Receipts from: |
|
|
|
|
|
|
Non-life insurance claims |
|
|
|
|
- |
|
Operating subsidies |
|
|
|
|
62.895,41 |
|
Cash at bank and its equivalents not available for use |
|
|
|
|
- |
ASSETS IMPAIRMENT
|
|
MOVIMENTOS DO PERIODO DE 2016 |
|
||||
|
|
IMPAIRMENT LOSSES |
|
IMPAIRMENT LOSSES REVERSALS |
|
||
|
RUBRICS |
RECOGNIZED
IN PROFIT
AND LOSS |
ON
REVALUED ASSETS RECOGNIZED
IN EQUITY |
TOTAL |
RECOGNIZED
IN PROFIT
AND LOSS |
RECOGNIZED
IN EQUITY |
TOTAL |
|
Individual assets |
|
|
|
|
|
|
|
Fixed tangible assets |
0,00 |
- |
- |
0,00 |
- |
- |
|
Goodwill |
- |
- |
- |
0,00 |
- |
- |
|
Intangible assets |
0,00 |
- |
- |
0,00 |
- |
- |
|
Investment
properties (cost model) |
0,00 |
- |
- |
0,00 |
- |
- |
|
Investments in progress |
0,00 |
- |
- |
0,00 |
- |
- |
|
Financial investments |
0,00 |
- |
- |
0,00 |
- |
- |
|
TOTAL |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
of which: cash-generating units |
0,00 |
- |
- |
0,00 |
- |
- |
GOVERNMENT GRANTS AND GOVERNMENT ASSISTANCE
|
|
GRANTS
FROM STATE AND OTHER PUBLIC
BODIES |
GRANTS
FROM OTHER ENTITIES |
||
|
RUBRICS |
VALUE
ASSIGNED IN THE
PERIOD OR IN
PREVIOUS PERIODS |
VALUE
ATTRIBUTED TO THE
PERIOD |
VALUE
ASSIGNED IN THE
PERIOD OR IN
PREVIOUS PERIODS |
VALUE ATTRIBUTED
TO THE
PERIOD |
|
Grants related to
assets/investment: |
- |
17.489,55 |
- |
0,00 |
|
Fixed tangible assets |
- |
17.489,55 |
- |
0,00 |
|
Land and Natural Resources |
- |
- |
- |
- |
|
Buildings and other structures |
- |
- |
- |
- |
|
Basic equipment |
- |
- |
- |
- |
|
Transport equipment |
- |
- |
- |
- |
|
Office equipment |
- |
17.489,55 |
- |
- |
|
Biological equipment |
- |
- |
- |
- |
|
Others |
- |
- |
- |
- |
|
Intangible assets |
- |
0,00 |
- |
0,00 |
|
Development projects |
- |
- |
- |
- |
|
Computer programmes |
- |
- |
- |
- |
|
Industrial property |
- |
- |
- |
- |
|
Others |
- |
- |
- |
- |
|
Other assets |
- |
- |
- |
- |
|
Grants related to income / operating |
- |
62.895,41 |
- |
- |
|
Value of repayments in the period: |
- |
0,00 |
- |
0,00 |
|
Grants related to
assets/investment |
- |
- |
- |
- |
|
Grants related to income / operating |
- |
- |
- |
- |
|
TOTAL |
- |
80.384,96 |
- |
0,00 |
IMPAIRMENT
LOSSES IN FINANCIAL ASSETS AT COST OR AT AMORTIZED COST
|
|
|
MOVIMENTOS DO PERIODO DE 2016 |
||
|
RUBRICS |
|
IMPAIRMENT
LOSSES |
IMPAIRMENT
LOSSES REVERSALS |
TOTAL |
|
Receivable debts from customers |
|
- |
13.623,59 |
(13.623,59) |
|
Other receivables |
|
- |
- |
0,00 |
|
Equity instruments and other securities |
|
- |
- |
0,00 |
|
Others |
|
- |
- |
0,00 |
|
TOTAL |
|
0,00 |
13.623,59 |
(13.623,59) |
|
DEBTS
REGISTERED AS DOUBTFUL |
|
|
RUBRICS |
VALUE |
|
Regarding insolvency and company recovery
procedures or enforcement procedures |
- |
|
Claimed in court |
- |
|
In arrears: |
0,00 |
|
Over six months and up to twelve months |
- |
|
Over twelve months
and up to eighteen months |
- |
|
Over eighteen months
and up to twenty four months |
- |
|
Over twenty four months |
- |
|
TOTAL |
0,00 |
EMPLOYEE BENEFITS, COMPANY EMPLOYEES AND PERSONNEL COSTS
|
|
AVERAGE NUMBER OF |
AVERAGE NUMBER OF |
|
RUBRICS |
|
|
|
|
EMPLOYEES |
HOURS WORKED |
|
Company employees,
paid and unpaid |
279 |
525.312 |
|
Paid company employees |
279 |
525.312 |
|
Company UNPAID employees |
0 |
0 |
|
Company employees, by type of working hours |
|
|
|
Full time company employees |
279 |
525.312 |
|
Of which: Full time
company employees |
279 |
525.312 |
|
Part time company
employees |
0 |
0 |
|
Of which: Part time company employees |
0 |
0 |
|
Company employees, by gender: |
|
|
|
Men |
101 |
190.167 |
|
Women |
178 |
335.145 |
|
Company employees, of which: |
|
|
|
Company employees
assigned to Research and Development |
0 |
- |
|
Service providers |
0 |
0 |
|
People placed through temporary employment agencies |
0 |
- |
|
STAFF COSTS |
|
|
|
RUBRICS |
|
VALUE |
|
Staff
costs |
5.283.524,77 |
|
Governance Bodies Remuneration |
176.870,98 |
|
Of which: Profit-sharing |
- |
|
Employees remuneration |
4.147.547,31 |
|
Of which: Profit-sharing |
- |
|
Post-employment benefits |
0,00 |
|
Pension premiums |
- |
|
Other benefits |
- |
|
Of which: |
|
|
For defined contribution plans - corporate bodies |
- |
|
For defined contribution plans - others |
- |
|
Compensations |
- |
|
Charges on remunerations |
912.006,58 |
|
Insurance for accidents at
work and professional diseases |
29.818,46 |
|
Social security expenses |
- |
|
Other staff costs |
17.281,44 |
|
Of which: |
|
|
Expenditure on education |
2.559,65 |
|
Expenditure on uniforms |
- |
INFORMATION
BY GEOGRAPHIC MARKETS
|
|
|
GEOGRAPHIC MARKETS |
|
|
|
RUBRICS |
INTERNAL |
EU |
EXTRA-EU |
TOTAL |
|
Sales |
13.486.876,56 |
1.391.269,93 |
2.883,62 |
14.881.030,11 |
|
Services provided |
440.367,95 |
72.090,72 |
670,00 |
513.128,67 |
|
Purchases |
2.583.066,78 |
3.043.290,19 |
718.534,25 |
6.344.891,22 |
|
Supplies and
external services |
2.436.666,76 |
145.643,20 |
106.899,79 |
2.689.209,75 |
|
Acquisition of fixed tangible assets |
925.425,04 |
179.209,30 |
- |
1.104.634,34 |
|
Acquisition of investment properties |
- |
- |
- |
0,00 |
|
Acquisition of intangible assets |
60.000,00 |
- |
- |
60.000,00 |
|
Supplementary income: |
0,00 |
0,00 |
0,00 |
0,00 |
|
Social services |
- |
- |
- |
0,00 |
|
Equipment rental |
- |
- |
- |
0,00 |
|
Studies, projects
and technological assistance |
- |
- |
- |
0,00 |
|
Royalities |
- |
- |
- |
0,00 |
|
Others |
- |
- |
- |
0,00 |
|
Memorandum: Sales
and services provided (undiscounted values) |
- |
- |
- |
0,00 |
|
Memorandum: Purchases and supplies and external services (undiscounted
values) |
- |
- |
- |
0,00 |
RECEIVABLE
AND PAYABLE ACCOUNTS
|
RUBRICS |
2016 |
2015 |
PERIODS |
|
CUSTOMERS |
|
|
|
|
Trade accounts receivable |
3.900.431,46 |
3.392.320,03 |
14,98% |
|
Trade notes receivable |
2.854.634,95 |
2.093.487,49 |
36,36% |
|
Advances received
from customers |
117.815,80 |
54.074,71 |
117,88% |
|
SUPPLIERS |
|
|
|
|
Trade accounts payable |
1.980.815,84 |
990.837,16 |
99,91% |
|
Trade notes payable |
- |
- |
- |
|
Trade accounts payable - unchecked invoices |
- |
- |
- |
|
Advances to suppliers |
47.769,71 |
60.834,12 |
(21,48)% |
|
STAFF |
|
|
|
|
Payable remunerations |
263.151,68 |
238.720,80 |
10,23% |
|
Advanced payments |
- |
- |
- |
|
Bonds |
- |
- |
- |
|
Other operations |
- |
- |
- |
|
STATE AND OTHER PUBLIC SECTOR INSTITUTIONS |
|
|
|
|
Income Tax |
164.079,59 |
- |
- |
|
Deductible IVA (debt cumulative amounts) |
1.952.761,07 |
1.753.388,37 |
11,37% |
|
Paid IVA (credit cumulative amounts) |
3.967.407,44 |
3.751.091,70 |
5,77% |
|
SHAREHOLDERS / PARTNERS |
|
|
|
|
Shareholders with subscription |
- |
- |
- |
|
Unreleased quotas |
- |
- |
- |
|
Advances for profits |
- |
- |
- |
|
ALLOCATED RESULTS |
|
|
|
|
From the perspective of the entity distributing profits |
- |
- |
- |
|
From the perspective of the entity with allocated profits |
- |
- |
- |
|
AVAILABLE PROFITS |
|
|
|
|
From the perspective of the entity distributing profits |
607,50 |
- |
- |
|
From the perspective of the entity with allocated profits |
- |
- |
- |
|
Granted loans - parent company |
- |
- |
- |
|
Granted loans - subsidiary companies, associated companies and joint |
|
|
|
|
|
- |
- |
- |
|
ventures |
|
|
|
|
Granted loans -
other shareholders/partners |
- |
- |
- |
|
Of which: Participating companies |
- |
- |
- |
|
OTHER OPERATIONS |
|
|
|
|
Debit status |
- |
- |
- |
|
Credit status |
- |
- |
- |
|
OTHER RECEIVABLE AND PAYABLE ACCOUNTS |
|
|
|
|
Investment
providers - general accounts |
- |
- |
- |
|
Trade accounts payable - unchecked invoices |
- |
- |
- |
|
Advanced payments
to investment providers |
- |
2.674,00 |
- |
|
additional income -
Debtors |
1.751,49 |
5.917,01 |
(70,40)% |
|
additional expenses
- Creditors |
625.252,74 |
588.108,39 |
6,32% |
|
Deferred tax assets |
428.175,24 |
501.817,41 |
(14,68)% |
|
Deferred tax liabilities |
- |
- |
- |
|
Unreleased subscriptions - Creditors |
- |
- |
- |
|
Advances received
on account of sales |
- |
- |
- |
|
OTHER DEBTORS AND CREDITORS |
|
|
|
|
Other debtors |
144.359,76 |
313.626,91 |
(53,97)% |
|
Other creditors |
4.141,64 |
4.030,94 |
2,75% |
|
EXPENSE
ACCOUNTS |
|
|
|
|
RUBRICS |
2016 |
2015 |
PERIODS |
|
Supplies and
external services |
2.689.209,75 |
2.399.853,19 |
12,06% |
|
Subcontracts |
- |
- |
- |
|
Specialized services |
1.467.023,93 |
1.307.514,06 |
12,20% |
|
Specialized works |
539.484,67 |
508.968,55 |
6,00% |
|
Of which: Payments to workers placed through agencies |
- |
- |
- |
|
Advertising and promotion |
396.298,03 |
377.790,43 |
4,90% |
|
Surveillance and security |
2.345,56 |
2.298,63 |
2,04% |
|
Fees |
164.834,58 |
171.795,66 |
(4,05)% |
|
Comissions |
- |
- |
- |
|
Maintenance and repairs |
335.904,95 |
187.538,05 |
79,11% |
|
Others |
28.156,14 |
59.122,74 |
(52,38)% |
|
Materials |
273.382,70 |
193.448,82 |
41,32% |
|
Fast wear tools and utensils |
253.744,98 |
169.527,59 |
49,68% |
|
Books and technical
documentation |
- |
388,62 |
- |
|
Office material |
10.475,52 |
13.223,89 |
(20,78)% |
|
Gift items |
9.162,20 |
10.308,72 |
(11,12)% |
|
Others |
- |
- |
- |
|
Energy and fluids |
430.536,31 |
378.607,40 |
13,72% |
|
Electricity |
224.972,68 |
202.930,64 |
10,86% |
|
Fuels |
71.471,53 |
73.692,81 |
(3,01)% |
|
Water |
23.182,21 |
21.808,13 |
6,30% |
|
Others |
110.909,89 |
80.175,82 |
38,33% |
|
Travel, lodging and
transportation |
160.303,67 |
131.640,18 |
21,77% |
|
Travel and lodging |
92.616,14 |
86.993,09 |
6,46% |
|
Transport of personnel |
- |
- |
- |
|
Transport of goods |
49.172,99 |
28.391,48 |
73,20% |
|
Others |
18.514,54 |
16.255,61 |
13,90% |
|
Different services |
357.963,14 |
388.642,73 |
(7,89)% |
|
Rents and leases |
206.872,54 |
225.666,68 |
(8,33)% |
|
Of which: Rents from land |
- |
- |
- |
|
Communication |
45.474,69 |
43.239,20 |
5,17% |
|
Insurance |
17.915,14 |
18.444,56 |
(2,87)% |
|
Royalties |
- |
- |
- |
|
Litigation and Notaries |
2.939,23 |
13.521,40 |
(78,26)% |
|
Representation expenses |
15.832,73 |
22.963,14 |
(31,05)% |
|
Cleaning, hygiene
and comfort |
21.947,75 |
20.005,67 |
9,71% |
|
Other services |
46.981,06 |
44.802,08 |
4,86% |
DELIBERATION OF APPROVAL OF ACCOUNTS
Were
the financial year's accounts approved?
YES
Data
da Aprovação: 17-05-2017 By (Unanimity/Majority):
Unanimity
Percentage
of issued votes related to the share capital subscribed with voting right 100
The
accounts were approved:
In universal meeting
Through deliberation by writing vote
The
accounts were approved:
In POC/SNC/NCM (National Plan of Accounts/Accounting
Normalization System/Accounting Normalization for micro entities)
PROFIT
APLICATION ACCORDING TO THE DELIBERATION THAT APPROVED THE FINANCIAL YEAR'S
ACCOUNTS
|
RUBRICS |
2016 |
2015 |
|
Retained earnings |
2.797.663,10 |
1.962.057,93 |
|
Allocated results / Available profits |
0,00 |
0,00 |
|
Percentages or bonuses to managing bodies |
- |
- |
|
Ditto to staff |
- |
- |
|
Reserves |
50.130,33 |
30.220,24 |
|
Coverage of losses |
- |
- |
|
7. Others |
- |
- |
|
BALANCE (1-2-3-4-5-6-7) |
2.747.532,77 |
1.931.837,69 |
MANAGEMENT REPORT / ASSESSMENT OF THE INSPECTION BODY / LEGAL CERTIFICATION OF ACCOUNTS
MANAGEMENT
REPORT
Were the Management Report and financial year's accounts
prepared?
YES
Were the management report and the financial year's accounts
signed by all members of the management / administration?
YES
ASSESSMENT
OF THE INSPECTION BODY
The entity has an inspection body?
YES
Has the inspection body issued an assessment?
YES
The inspection body pronounced:
In favour of the approval of accounts
LEGAL
CERTIFICATION OF ACCOUNTS (CLC)
Is the entity required to have certified accounts by a
Statutory Auditor/Statutory Audit Firm?
YES
Identificação do ROC: 505261898
Was the Legal certification of accounts issued?
YES
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 65.82 |
|
|
1 |
INR 90.40 |
|
Euro |
1 |
INR 79.76 |
|
Euro |
1 |
INR 79.69 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
NIY |
|
|
|
|
Report Prepared
by : |
KET |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.